诺华-话题@MedSci

#诺华#

235篇内容 | 5218人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1282633, encodeId=608a12826334c, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华计划测试两种阿尔兹海默症药物, objectType=article, longId=38063, objectId=c15b38063e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15b38063e8, replyNumber=0, likeNumber=100, createdTime=2014-07-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15b38063e8, moduleTitle=诺华计划测试两种阿尔兹海默症药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15b38063e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282632, encodeId=9b46128263298, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=谷歌携手诺华开发智能隐形眼镜可测血糖矫视力, objectType=article, longId=37916, objectId=a4083e9164d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4083e9164d, replyNumber=0, likeNumber=64, createdTime=2014-07-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4083e9164d, moduleTitle=谷歌携手诺华开发智能隐形眼镜可测血糖矫视力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4083e9164d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282631, encodeId=f8bc1282631e1, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华CAR-T疗法获得FDA突破性疗法认证, objectType=article, longId=37655, objectId=60823e6550d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60823e6550d, replyNumber=0, likeNumber=67, createdTime=2014-07-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60823e6550d, moduleTitle=诺华CAR-T疗法获得FDA突破性疗法认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60823e6550d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282630, encodeId=60391282630c4, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=2014年全球制药企业排行榜诺华居首 (2014 Pharm Exec top50), objectType=article, longId=36427, objectId=d6173642ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6173642ef7, replyNumber=0, likeNumber=61, createdTime=2014-06-16, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6173642ef7, moduleTitle=2014年全球制药企业排行榜诺华居首 (2014 Pharm Exec top50), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6173642ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282629, encodeId=564912826293a, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华公布新获批抗癌药Zykadia积极数据, objectType=article, longId=36078, objectId=c72b360e89b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c72b360e89b, replyNumber=0, likeNumber=69, createdTime=2014-06-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c72b360e89b, moduleTitle=诺华公布新获批抗癌药Zykadia积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c72b360e89b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282628, encodeId=50f21282628ba, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA拒绝诺华心衰药物Serelaxin, objectType=article, longId=35454, objectId=3baf3545475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3baf3545475, replyNumber=0, likeNumber=83, createdTime=2014-05-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3baf3545475, moduleTitle=FDA拒绝诺华心衰药物Serelaxin, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3baf3545475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282627, encodeId=af8f128262e29, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华COPD药物Onbrez疗效与GSK Seretide媲美, objectType=article, longId=34602, objectId=28f8346027d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f8346027d, replyNumber=0, likeNumber=72, createdTime=2014-05-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f8346027d, moduleTitle=诺华COPD药物Onbrez疗效与GSK Seretide媲美, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f8346027d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282626, encodeId=7b3b12826261b, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华提请禁止印度百康推出其维格列汀仿制药, objectType=article, longId=33255, objectId=4d633325514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d633325514, replyNumber=0, likeNumber=56, createdTime=2014-04-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d633325514, moduleTitle=诺华提请禁止印度百康推出其维格列汀仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d633325514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282625, encodeId=cf3c128262596, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=法国反垄断机构就眼科药物对罗氏与诺华展开调查, objectType=article, longId=33237, objectId=ed183323e02, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed183323e02, replyNumber=0, likeNumber=59, createdTime=2014-04-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed183323e02, moduleTitle=法国反垄断机构就眼科药物对罗氏与诺华展开调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed183323e02)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282624, encodeId=d94a1282624b7, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA授予诺华脑膜炎疫苗Bexsero突破性疗法认定, objectType=article, longId=33004, objectId=f37d33004ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f37d33004ad, replyNumber=0, likeNumber=65, createdTime=2014-04-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f37d33004ad, moduleTitle=FDA授予诺华脑膜炎疫苗Bexsero突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f37d33004ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282623, encodeId=96c7128262332, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华心血管药物研究团队寄希望于新药LCZ696, objectType=article, longId=32790, objectId=73b932e90fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b932e90fd, replyNumber=0, likeNumber=59, createdTime=2014-04-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b932e90fd, moduleTitle=诺华心血管药物研究团队寄希望于新药LCZ696, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b932e90fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282622, encodeId=b0e1128262284, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA心血管委员会全票否决诺华心衰注射剂, objectType=article, longId=32611, objectId=f9f232611fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9f232611fa, replyNumber=0, likeNumber=79, createdTime=2014-04-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9f232611fa, moduleTitle=FDA心血管委员会全票否决诺华心衰注射剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9f232611fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282621, encodeId=8cae128262136, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=英国将推广诺华乙型脑膜炎疫苗, objectType=article, longId=32382, objectId=db65323825b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db65323825b, replyNumber=0, likeNumber=68, createdTime=2014-03-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db65323825b, moduleTitle=英国将推广诺华乙型脑膜炎疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db65323825b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282620, encodeId=3c1f128262067, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华在欧洲推出Lucentis预充注射剂, objectType=article, longId=32200, objectId=2631322004c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2631322004c, replyNumber=0, likeNumber=57, createdTime=2014-03-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2631322004c, moduleTitle=诺华在欧洲推出Lucentis预充注射剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2631322004c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282619, encodeId=86dc128261982, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华Jakavi III期试验达主要终点, objectType=article, longId=31686, objectId=87cd3168624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87cd3168624, replyNumber=0, likeNumber=72, createdTime=2014-03-12, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87cd3168624, moduleTitle=诺华Jakavi III期试验达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87cd3168624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282618, encodeId=4b171282618d5, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华单抗药索雷尔（Xolair）新适应症获欧盟批准, objectType=article, longId=31628, objectId=44263162852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44263162852, replyNumber=0, likeNumber=84, createdTime=2014-03-09, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44263162852, moduleTitle=诺华单抗药索雷尔（Xolair）新适应症获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44263162852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282617, encodeId=492a128261e98, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华Lucentis获日本批准用于DME治疗, objectType=article, longId=31076, objectId=8d36310e6e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d36310e6e8, replyNumber=0, likeNumber=68, createdTime=2014-02-26, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d36310e6e8, moduleTitle=诺华Lucentis获日本批准用于DME治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d36310e6e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282616, encodeId=f00f1282616fc, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华抗癌药LDE225关键性BOLT研究达主要终点, objectType=article, longId=30912, objectId=3e72309122a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e72309122a, replyNumber=0, likeNumber=72, createdTime=2014-02-22, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e72309122a, moduleTitle=诺华抗癌药LDE225关键性BOLT研究达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e72309122a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282615, encodeId=65a51282615f2, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华关闭美国代文工厂并裁员525人, objectType=article, longId=29983, objectId=35852998338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35852998338, replyNumber=0, likeNumber=50, createdTime=2014-01-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35852998338, moduleTitle=诺华关闭美国代文工厂并裁员525人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35852998338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282614, encodeId=e96b12826143f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华拟重组瑞士部分业务并在制药部门裁员500人, objectType=article, longId=29883, objectId=f50129883e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f50129883e2, replyNumber=0, likeNumber=60, createdTime=2014-01-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f50129883e2, moduleTitle=诺华拟重组瑞士部分业务并在制药部门裁员500人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f50129883e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诺华

2020-05-29发表于威斯康星

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华计划测试两种阿尔兹海默症药物

2014-07-23

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

谷歌携手诺华开发智能隐形眼镜可测血糖矫视力

2014-07-18

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华CAR-T疗法获得FDA突破性疗法认证

2014-07-12

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

2014年全球制药企业排行榜诺华居首 (2014 Pharm Exec top50)

2014-06-16

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华公布新获批抗癌药Zykadia积极数据

2014-06-07

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA拒绝诺华心衰药物Serelaxin

2014-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华COPD药物Onbrez疗效与GSK Seretide媲美

2014-05-14

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华提请禁止印度百康推出其维格列汀仿制药

2014-04-13

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

法国反垄断机构就眼科药物对罗氏与诺华展开调查

2014-04-13

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA授予诺华脑膜炎疫苗Bexsero突破性疗法认定

2014-04-10

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华心血管药物研究团队寄希望于新药LCZ696

2014-04-04

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA心血管委员会全票否决诺华心衰注射剂

2014-04-02

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

英国将推广诺华乙型脑膜炎疫苗

2014-03-27

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华在欧洲推出Lucentis预充注射剂

2014-03-23

docwu2019 (审核中...)

前往app查看评论内容

#诺华#

诺华Jakavi III期试验达主要终点

2014-03-12

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华单抗药索雷尔（Xolair）新适应症获欧盟批准

2014-03-09

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华Lucentis获日本批准用于DME治疗

2014-02-26

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华抗癌药LDE225关键性BOLT研究达主要终点

2014-02-22

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华关闭美国代文工厂并裁员525人

2014-01-27

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华拟重组瑞士部分业务并在制药部门裁员500人

2014-01-25

科室
- - 订阅+
  - 更多科室
工具
服务